Oppenheimer has published a report on Clorox CLX downgrading the company.
In the report, Oppenheimer wrote that, "We are downgrading CLX to Perform from Outperform and suggest investors use Friday's strength and all-time high stock price to take profits on the heels of Carl Icahn's bid for the company (which is likely to be rejected, in our view). The shares are trading at a valuation not supported by fundamentals, and we are skeptical that a superior bid will materialize."
Oppenheimer downgraded Clorox to Perform with no current price target. Clorox closed Friday at $74.55.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorDowngradesAnalyst RatingscloroxConsumer StaplesHousehold ProductsOppenheimer
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in